Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
Filippo Valbusa(Ospedale Sacro Cuore Don Calabria), Giovanni Targher(Azienda Ospedaliera Universitaria Integrata Verona), Guido Arcaro(Ospedale Sacro Cuore Don Calabria), Pietro Arduini(Ospedale Sacro Cuore Don Calabria), Giacomo Zoppini(University of Verona), Stefano Calabria(Ospedale Sacro Cuore Don Calabria), Luca Scala(Ospedale Sacro Cuore Don Calabria), Alessandro Mantovani(Azienda Ospedaliera Universitaria Integrata Verona), Davide Agnoletti(Ospedale Sacro Cuore Don Calabria), Cristina Grillo(Ospedale Sacro Cuore Don Calabria), Giuliana Scaturro(Ospedale Sacro Cuore Don Calabria), E Turcato(University of Verona), Aldo P. Maggioni, Stefano Bonapace(Ospedale Sacro Cuore Don Calabria)
Cited by 56
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
NAFLD: A multisystem disease
|Journal of Hepatology|2015|3.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k